Advertisment

Intas Pharmaceuticals

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice (CGMP) regulat...
USFDA issues warning letter to Intas Pharma for Sanand plant
USFDA issues warning letter to Intas Pharma for Sanand plant
Advertisment
Subscribe